Federal contract award

HT942523C0061

DHA PH II SEQL PROPOSAL H2S-0045, TITLE: BROAD-SPECTRUM SNAKEBITE ANTIDOTE: METALLOPROTEASE INHIBITION TO IMPROVE RECOVERY TIME FOLLOWING SNAKEBITE, MEDICAL R & D EGS 23000510

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Defense
OfficeARMY MED RES ACQ ACTIVITY
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Parent award / vehicleNot reported
Set-asideSMALL BUSINESS SET ASIDE - TOTAL
Pricing typeFIRM FIXED PRICE
Obligations$1.3M
Current contract value$1.3M
Potential contract value / ceiling$1.3M
Start dateAug 25, 2023
Current end dateDec 24, 2025
Potential end dateDec 24, 2025
Latest award activityOct 30, 2023
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Oct 30, 2023P00001$0DHA PH II SEQL PROPOSAL H2S-0045, TITLE: BROAD-SPECTRUM SNAKEBITE ANTIDOTE: METALLOPROTEASE INHIBITION TO IMPROVE RECOVERY TIME FOLLOWING SNAKEBITE, MEDICAL R & D EGS 23000510
Aug 22, 20230$1.3MDHA PH II SEQL PROPOSAL H2S-0045, TITLE: BROAD-SPECTRUM SNAKEBITE ANTIDOTE: METALLOPROTEASE INHIBITION TO IMPROVE RECOVERY TIME FOLLOWING SNAKEBITE, MEDICAL R & D EGS 23000510

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.